A detailed history of Decheng Capital LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 4,447,308 shares of EQ stock, worth $3.34 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
4,447,308
Previous 4,447,308 -0.0%
Holding current value
$3.34 Million
Previous $10.3 Billion 69.99%
% of portfolio
0.94%
Previous 1.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.48 - $0.74 $2.13 Million - $3.29 Million
4,447,308 New
4,447,308 $3.22 Billion

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $25.8M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.